Find out whether high-dose aspirin remains necessary during acute-stage Kawasaki disease treatment. Learn more.

Bayer officials say the legislation is key to keep the sale of glyphosate in the U.S. and not risk the closure of its Muscatine plant.

The clinical trial will include nearly 150 patients with advanced hepatocellular carcinoma that expresses glypican-3.

The DEA Museum explores Bayer's early 20th-century marketing of heroin, originally promoted as a "less addictive" morphine ...

Bayer is boosting its precision oncology efforts with a molecular database from health tech firm ConcertAI.  | Bayer is ...

A new publication in the British Medical Journal reviewed current clinical data and found NSAIDs like Aleve and Bayer Aspirin ...

Bayer AG (Leverkusen, Germany) announced the grand opening of its new 70,000 square foot expansion at its Myerstown, ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. A plane carrying migrants from Central Asia and ...

Bayer says it may stop producing glyphosate—the world’s most widely used weedkiller—unless it receives court protection from lawsuits alleging the chemical causes cancer. According to the Wall Street ...

Bayer is lobbying U.S. states to adjust their regulations in the battle to control costly litigation targeting its herbicide ...

Based on these recent guidelines for use of aspirin in primary prevention, as well as the supportive clinical evidence and potential benefits, Bayer HealthCare, makers of Bayer Aspirin ...